Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

Kazimierz Groen; Fredrik H Schjesvold; Bronno van der Holt; Mark-David Levin; Maarten R Seefat; Markus Hansson; Maria B L Leys; Josien C Regelink; Anders Waage; Damian Szatkowski; Per Axelsson; Trung Hieu Do; Asta Svirskaite; Ellen van der Spek; Einar Haukas; Dorota Knut-Bojanowska; Paula F Ypma; Cecilie H Blimark; Ulf-Henrik Mellqvist; Niels W C J van de Donk; Pieter Sonneveld; Anja Klostergaard; Annette J Vangsted; Niels Abildgaard; Sonja Zweegman

doi:10.1097/HS9.0000000000000940

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

Kazimierz Groen, Fredrik H Schjesvold, Bronno van der Holt, Mark-David Levin, Maarten R Seefat, Markus Hansson, Maria B L Leys, Josien C Regelink, Anders Waage, Damian Szatkowski, Per Axelsson, Trung Hieu Do, Asta Svirskaite, Ellen van der Spek, Einar Haukas, Dorota Knut-Bojanowska, Paula F Ypma, Cecilie H Blimark, Ulf-Henrik Mellqvist, Niels W C J van de DonkPieter Sonneveld, Anja Klostergaard, Annette J Vangsted, Niels Abildgaard, Sonja Zweegman^*

^*Corresponding author af dette arbejde

Afdeling for Blodsygdomme

1 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	HemaSphere
Vol/bind	7
Udgave nummer	9
Sider (fra-til)	e940
ISSN	2572-9241
DOI	https://doi.org/10.1097/HS9.0000000000000940
Status	Udgivet - sep. 2023

Adgang til dokumentet

10.1097/HS9.0000000000000940

Andre filer og links

Link to publication in Scopus

Citationsformater

Groen, K., Schjesvold, F. H., van der Holt, B., Levin, M.-D., Seefat, M. R., Hansson, M., Leys, M. B. L., Regelink, J. C., Waage, A., Szatkowski, D., Axelsson, P., Hieu Do, T., Svirskaite, A., van der Spek, E., Haukas, E., Knut-Bojanowska, D., Ypma, P. F., Blimark, C. H., Mellqvist, U.-H., ... Zweegman, S. (2023). Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13. HemaSphere, 7(9), e940. https://doi.org/10.1097/HS9.0000000000000940

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13. / Groen, Kazimierz; Schjesvold, Fredrik H; van der Holt, Bronno et al.
I: HemaSphere, Bind 7, Nr. 9, 09.2023, s. e940.

Publikation: Bidrag til tidsskrift › Letter › peer review

Groen, K, Schjesvold, FH, van der Holt, B, Levin, M-D, Seefat, MR, Hansson, M, Leys, MBL, Regelink, JC, Waage, A, Szatkowski, D, Axelsson, P, Hieu Do, T, Svirskaite, A, van der Spek, E, Haukas, E, Knut-Bojanowska, D, Ypma, PF, Blimark, CH, Mellqvist, U-H, van de Donk, NWCJ, Sonneveld, P, Klostergaard, A, Vangsted, AJ, Abildgaard, N & Zweegman, S 2023, 'Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13', HemaSphere, bind 7, nr. 9, s. e940. https://doi.org/10.1097/HS9.0000000000000940

@article{36dfe74f741e433abc0a58cd1b730757,

title = "Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13",

author = "Kazimierz Groen and Schjesvold, {Fredrik H} and {van der Holt}, Bronno and Mark-David Levin and Seefat, {Maarten R} and Markus Hansson and Leys, {Maria B L} and Regelink, {Josien C} and Anders Waage and Damian Szatkowski and Per Axelsson and {Hieu Do}, Trung and Asta Svirskaite and {van der Spek}, Ellen and Einar Haukas and Dorota Knut-Bojanowska and Ypma, {Paula F} and Blimark, {Cecilie H} and Ulf-Henrik Mellqvist and {van de Donk}, {Niels W C J} and Pieter Sonneveld and Anja Klostergaard and Vangsted, {Annette J} and Niels Abildgaard and Sonja Zweegman",

year = "2023",

month = sep,

doi = "10.1097/HS9.0000000000000940",

language = "English",

volume = "7",

pages = "e940",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley and Sons Inc.",

number = "9",

}

TY - JOUR

T1 - Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients

T2 - Long-term Results of HOVON-126/NMSG 21.13

AU - Groen, Kazimierz

AU - Schjesvold, Fredrik H

AU - van der Holt, Bronno

AU - Levin, Mark-David

AU - Seefat, Maarten R

AU - Hansson, Markus

AU - Leys, Maria B L

AU - Regelink, Josien C

AU - Waage, Anders

AU - Szatkowski, Damian

AU - Axelsson, Per

AU - Hieu Do, Trung

AU - Svirskaite, Asta

AU - van der Spek, Ellen

AU - Haukas, Einar

AU - Knut-Bojanowska, Dorota

AU - Ypma, Paula F

AU - Blimark, Cecilie H

AU - Mellqvist, Ulf-Henrik

AU - van de Donk, Niels W C J

AU - Sonneveld, Pieter

AU - Klostergaard, Anja

AU - Vangsted, Annette J

AU - Abildgaard, Niels

AU - Zweegman, Sonja

PY - 2023/9

Y1 - 2023/9

UR - http://www.scopus.com/inward/record.url?scp=85171177792&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000940

DO - 10.1097/HS9.0000000000000940

M3 - Letter

C2 - 37663673

SN - 2572-9241

VL - 7

SP - e940

JO - HemaSphere

JF - HemaSphere

IS - 9

ER -